Welcome to our dedicated page for Zimmer Biomet SEC filings (Ticker: ZBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zimmer Biomet Holdings, Inc. (NYSE: ZBH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Zimmer Biomet is a global medical technology company focused on musculoskeletal health and orthopedic implants, and its filings offer detailed insight into its operations, capital structure, risk factors and governance.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Zimmer Biomet’s product categories such as knees, hips, sports medicine, extremities, trauma, craniomaxillofacial and thoracic (S.E.T.), and technology and data, bone cement and surgical. These reports typically include segment and geographic sales information, descriptions of the company’s digital and robotic technologies, and management’s discussion and analysis.
You will also find current reports on Form 8-K covering material events, including quarterly earnings releases, new debt issuances, revolving credit agreements, acquisitions such as the merger with Monogram Technologies Inc., and other significant corporate developments. Filings describing the company’s notes and bonds, including series listed on the New York Stock Exchange, provide detail on interest rates, maturities, covenants and redemption features.
Stock Titan enhances these documents with AI-powered summaries that explain key points in clear language, helping users navigate complex topics like non-GAAP financial measures, leverage covenants and transaction structures. The platform also surfaces insider and executive-related filings, such as those reporting departures or appointments of certain officers, so users can track governance changes. With real-time updates from EDGAR and AI-generated highlights, this page is a focused resource for analyzing Zimmer Biomet’s SEC reporting history and ongoing regulatory disclosures.
Zimmer Biomet Holdings has filed a Form S-8 to register securities under its 2009 Stock Incentive Plan. The company, a large accelerated filer headquartered in Warsaw, Indiana, is registering additional shares for employee benefits.
Key aspects of the filing include:
- Registration covers the amended and restated 2009 Stock Incentive Plan (referenced in 8-K filed June 3, 2025)
- Filing incorporates by reference several documents including the Annual Report for FY2024, Quarterly Report for Q1 2025, and proxy materials
- Includes comprehensive indemnification provisions for directors and officers under Delaware law
- Company maintains directors' and officers' liability insurance coverage
The filing includes standard undertakings regarding post-effective amendments and removal of unsold securities. Legal opinion and consent from PricewaterhouseCoopers LLP are filed as exhibits. This registration statement enables Zimmer Biomet to offer equity-based compensation to employees under its incentive plan.